Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
Protein export,6/23,7.457932178697259e-4,0.22970431110387557,0,0,5.217391304347825,37.57075922100706,SRP19;IMMP1L;SPCS3;SPCS2;SRPRB;SEC62
Adherens junction,8/72,0.026917281476999108,1,0,0,2.222222222222222,8.033303921239105,SMAD2;RAC3;MAPK1;PTPRJ;RAC1;NLK;TGFBR1;EGFR
FoxO signaling pathway,12/132,0.03290365815824255,1,0,0,1.8181818181818181,6.207584431221539,SMAD2;PRKAA1;IRS1;TGFB3;BNIP3;S1PR1;MAPK1;NLK;ATG12;TGFBR1;EGFR;INS
TGF-beta signaling pathway,9/90,0.03581529681696861,1,0,0,2,6.65876038289141,TGIF1;SMAD2;TGFB3;BAMBI;BMP8A;MAPK1;PITX2;TGFBR1;DCN
N-Glycan biosynthesis,6/50,0.03757690396507332,1,0,0,2.4,7.875277616560796,ALG8;FUT8;GANAB;MAN1C1;ALG12;ALG11
Fanconi anemia pathway,6/54,0.05175964311269336,1,0,0,2.222222222222222,6.580321164119916,ERCC4;RPA3;HES1;BRCA1;FANCB;FANCF
Homologous recombination,5/41,0.05234904272896249,1,0,0,2.4390243902439024,7.194686897103624,BABAM1;BARD1;RAD51B;RPA3;BRCA1
Phospholipase D signaling pathway,12/148,0.06766615426589831,1,0,0,1.6216216216216217,4.367301342263154,DNM3;CYTH3;KITLG;GRM7;DGKA;LPAR1;MAPK1;F2;RAPGEF3;EGFR;PLD2;INS
Type II diabetes mellitus,5/46,0.07838227433911542,1,0,0,2.1739130434782608,5.535124934351927,IRS1;CACNA1B;MAPK1;PRKCZ;INS
Pancreatic cancer,7/75,0.08063866676431897,1,0,0,1.8666666666666667,4.699850414889133,SMAD2;TGFB3;RAC3;MAPK1;RAC1;TGFBR1;EGFR
Antigen processing and presentation,7/77,0.08989981224700702,1,0,0,1.8181818181818181,4.380108047221139,KLRC4;NFYC;TAP2;TAP1;KIR3DL2;HLA-F;KIR3DL3
Prion diseases,4/35,0.09558057758683013,1,0,0,2.2857142857142856,5.366367183732389,PRNP;C8G;C7;MAPK1
Autophagy,10/128,0.10797771695705811,1,0,0,1.5625,3.4778599962772243,VMP1;PRKAA1;IRS1;MTMR14;BNIP3;MAPK1;HMGB1;AMBRA1;ATG12;INS
Aldosterone-regulated sodium reabsorption,4/37,0.11170784333278796,1,0,0,2.1621621621621623,4.739174827095357,IRS1;MAPK1;SFN;INS
AGE-RAGE signaling pathway in diabetic complications,8/100,0.12742605989598135,1,0,0,1.5999999999999999,3.2963504079810266,SMAD2;COL1A2;TGFB3;COL4A4;MAPK1;RAC1;PRKCZ;TGFBR1
Pyruvate metabolism,4/39,0.1289489055490016,1,0,0,2.051282051282051,4.201721095583098,LDHB;GRHPR;FH;ACACB
Renal cell carcinoma,6/69,0.13028256049309653,1,0,0,1.7391304347826086,3.5444341652133744,FH;TGFB3;RAPGEF1;MAPK1;ELOB;RAC1
"Glycine, serine and threonine metabolism",4/40,0.1379595947094308,1,0,0,2,3.961588857315027,GRHPR;ALAS2;GCAT;GNMT
Colorectal cancer,7/86,0.1385007496507468,1,0,0,1.627906976744186,3.2181759965349643,SMAD2;TGFB3;RAC3;MAPK1;RAC1;TGFBR1;EGFR
Maturity onset diabetes of the young,3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,HES1;BHLHA15;INS
Rap1 signaling pathway,14/206,0.15170562792130884,1,0,0,1.3592233009708736,2.5632413708877233,ITGB3;LPAR1;GNAI3;SIPA1L2;PRKCZ;EGFR;INS;KITLG;RAPGEF1;RAC3;RAPGEF2;MAPK1;RAC1;RAPGEF3
Phototransduction,3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,PDE6G;GNB1;CNGA1
Lysosome,9/123,0.16278961618226181,1,0,0,1.4634146341463412,2.6565316245543467,SCARB2;NAPSA;FUCA1;PSAP;M6PR;SLC17A5;ARSG;MCOLN1;LIPA
Endocytosis,16/244,0.16358113039626518,1,0,0,1.3114754098360655,2.3743556738908524,PSD;SMAD2;IQSEC3;ASAP2;HLA-F;PRKCZ;EGFR;RAB11A;TGFBR1;PLD2;DNM3;CYTH3;UBB;NEDD4;IL2RB;VPS25
Viral myocarditis,5/59,0.17159602546898528,1,0,0,1.694915254237288,2.987478396269761,SGCB;RAC3;RAC1;HLA-F;MYH6
Parkinson disease,10/142,0.17391136269914045,1,0,0,1.408450704225352,2.4636753793463417,UCHL1;UBA7;UBB;NDUFB11;NDUFS3;GNAI3;NDUFV3;DRD1;SDHA;SLC6A3
Long-term depression,5/60,0.18006686918004597,1,0,0,1.6666666666666665,2.8573783360576237,RYR1;GRID2;CRH;GNAI3;MAPK1
ABC transporters,4/45,0.18643368284604128,1,0,0,1.7777777777777777,2.98609722860718,ABCA6;TAP2;TAP1;ABCB11
Basal transcription factors,4/45,0.18643368284604128,1,0,0,1.7777777777777777,2.98609722860718,GTF2A1L;GTF2H1;GTF2E1;TAF1
Relaxin signaling pathway,9/130,0.20317246774459144,1,0,0,1.3846153846153846,2.206661629625701,SMAD2;COL1A2;COL4A4;GNB1;GNAI3;MAPK1;PRKCZ;TGFBR1;EGFR
"Phenylalanine, tyrosine and tryptophan biosynthesis",1/5,0.22623900494711593,1,0,0,4,5.9446531780071785,IL4I1
Spliceosome,9/134,0.2279349849994822,1,0,0,1.3432835820895521,1.9863065071379982,ISY1-RAB43;RBM25;EIF4A3;DDX23;SNRPG;DDX42;CDC5L;PRPF40A;HNRNPA1L2
HIF-1 signaling pathway,7/100,0.2335936861063974,1,0,0,1.4000000000000001,2.035840879866453,EIF4E1B;MAPK1;ELOB;CAMK2G;EGFR;PDK1;INS
Human cytomegalovirus infection,14/225,0.2369606122014638,1,0,0,1.2444444444444442,1.7918274514328554,IFNA7;PTGER1;ITGB3;GNAI3;TAP2;TAP1;HLA-F;EGFR;GNB1;CCL3;RAC3;MAPK1;RAC1;CCR3
Neurotrophin signaling pathway,8/119,0.24495576693425716,1,0,0,1.3445378151260503,1.8913312643532947,IRS1;IRAK2;RPS6KA2;RAPGEF1;MAPK1;IRAK3;RAC1;CAMK2G
Insulin signaling pathway,9/137,0.2472046870434335,1,0,0,1.313868613138686,1.8361820930540071,PRKAA1;PRKAR1B;IRS1;EIF4E1B;RAPGEF1;MAPK1;PRKCZ;ACACB;INS
Tyrosine metabolism,3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,GSTZ1;IL4I1;ADH5
Glycosaminoglycan biosynthesis,4/53,0.272750159994601,1,0,0,1.5094339622641508,1.9610551964847422,EXT1;EXT2;FUT8;HS3ST2
B cell receptor signaling pathway,5/71,0.2815854896327663,1,0,0,1.408450704225352,1.7849565976318464,CD72;RAC3;MAPK1;RAC1;CARD11
mRNA surveillance pathway,6/91,0.303383440861158,1,0,0,1.3186813186813187,1.5728674181927342,CPSF4;PABPC4;EIF4A3;CPSF2;MSI2;BCL2L2-PABPN1
Serotonergic synapse,7/113,0.3360072922265982,1,0,0,1.238938053097345,1.3512136129900216,DUSP1;GNB1;CACNA1B;GNAI3;MAPK1;HTR4;RAPGEF3
Sulfur relay system,1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TST
Amoebiasis,6/96,0.3479363200566363,1,0,0,1.25,1.3196697553688395,SERPINB1;C8G;COL1A2;TGFB3;COL4A4;LAMA3
Porphyrin and chlorophyll metabolism,3/42,0.3510272087326468,1,0,0,1.4285714285714284,1.4955593439482697,ALAS2;CPOX;UGT2A3
Complement and coagulation cascades,5/79,0.36105764852361333,1,0,0,1.2658227848101267,1.2895160027815111,C8G;C7;PROS1;ITGAX;F2
Glycerolipid metabolism,4/61,0.36421006738242967,1,0,0,1.3114754098360655,1.3246222552325246,GPAM;MOGAT2;DGKA;PNLIP
Type I diabetes mellitus,3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,GAD2;HLA-F;INS
Sulfur metabolism,1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TST
Cushing syndrome,9/155,0.37149900230097443,1,0,0,1.1612903225806452,1.1499202456539444,KMT2D;FH;FZD4;CRH;GNAI3;MAPK1;AHR;CAMK2G;EGFR
cAMP signaling pathway,12/212,0.3715469955016443,1,0,0,1.1320754716981132,1.120845193360484,EDN3;GNAI3;CNGA1;ATP2B4;RAC3;MAPK1;RAC1;DRD1;HTR4;CAMK2G;RAPGEF3;PLD2
Choline metabolism in cancer,6/99,0.37495373657039877,1,0,0,1.2121212121212122,1.1890334906277922,DGKA;RAC3;MAPK1;RAC1;EGFR;PLD2
Apelin signaling pathway,8/137,0.3782278714972952,1,0,0,1.167883211678832,1.1354842982136466,SMAD2;RYR1;PRKAA1;GNB1;GNAI3;MAPK1;TGFBR1;APLN
Sphingolipid signaling pathway,7/119,0.3853715393039042,1,0,0,1.176470588235294,1.1218204386945247,GNAI3;S1PR1;RAC3;MAPK1;RAC1;PRKCZ;PLD2
ECM-receptor interaction,5/82,0.39117601725719064,1,0,0,1.2195121951219512,1.1446312783908745,COL1A2;ITGB3;COL4A4;LAMA3;HSPG2
Wnt signaling pathway,9/158,0.3930161491766438,1,0,0,1.1392405063291138,1.0639419219166353,DKK4;FZD4;BAMBI;RAC3;ROR2;RAC1;NLK;CAMK2G;CER1
Fluid shear stress and atherosclerosis,8/139,0.39355473032009886,1,0,0,1.1510791366906474,1.0734217379560849,PRKAA1;GSTO2;DUSP1;ITGB3;PECAM1;RAC3;RAC1;PRKCZ
MAPK signaling pathway,16/295,0.40539466480088415,1,0,0,1.0847457627118644,0.979410663467526,DUSP1;TGFB3;CACNA1B;NLK;EGFR;TGFBR1;INS;ELK4;RPS6KA4;KITLG;RPS6KA2;RAC3;RAPGEF2;MAPK1;MAP3K8;RAC1
Hippo signaling pathway,9/160,0.4073910770526227,1,0,0,1.125,1.0102293873083648,SMAD2;MOB1B;TGFB3;FZD4;BMP8A;FAT4;PRKCZ;LLGL1;TGFBR1
PI3K-Akt signaling pathway,19/354,0.4086462551538806,1,0,0,1.0734463276836157,0.9606329141882789,IFNA7;PRKAA1;IRS1;ITGB3;LAMA3;LPAR1;OSM;BRCA1;EGFR;EPOR;INS;KITLG;COL1A2;COL4A4;EIF4E1B;GNB1;IL2RB;MAPK1;RAC1
Chagas disease (American trypanosomiasis),6/103,0.41102972546232486,1,0,0,1.1650485436893203,1.035832709563524,SMAD2;TGFB3;GNAI3;CCL3;MAPK1;TGFBR1
Axon guidance,10/181,0.41931924164335166,1,0,0,1.1049723756906076,0.9603566142967724,RGS3;DPYSL5;GNAI3;RAC3;MAPK1;SRGAP3;RAC1;PRKCZ;CAMK2G;PDK1
Cysteine and methionine metabolism,3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,IL4I1;LDHB;TST
Nucleotide excision repair,3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,ERCC4;RPA3;GTF2H1
Hypertrophic cardiomyopathy (HCM),5/85,0.42118396120911705,1,0,0,1.176470588235294,1.0172771508801166,PRKAA1;SGCB;TGFB3;ITGB3;MYH6
Proteoglycans in cancer,11/201,0.42334810143404067,1,0,0,1.0945273631840795,0.940812491424585,SMAD2;FZD4;ITGB3;COL21A1;MAPK1;RAC1;HPSE;HSPG2;CAMK2G;EGFR;DCN
Neuroactive ligand-receptor interaction,18/338,0.4259474701223244,1,0,0,1.0650887573964496,0.908988550176595,GRID2;EDN3;PTGER1;PMCH;MLNR;LPAR1;FPR3;HTR4;F2;APLN;UCN3;GRM7;GALR2;NPBWR1;CRH;S1PR1;F2RL1;DRD1
Taurine and hypotaurine metabolism,1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,GAD2
Ubiquinone and other terpenoid-quinone biosynthesis,1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,COQ2
Long-term potentiation,4/67,0.4327475179328833,1,0,0,1.1940298507462686,1.0001203826990046,RPS6KA2;MAPK1;CAMK2G;RAPGEF3
Arginine and proline metabolism,3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,PYCR1;LAP3;CKB
Cocaine addiction,3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,GNAI3;DRD1;SLC6A3
Citrate cycle (TCA cycle),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,FH;SDHA
Pentose phosphate pathway,2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,PRPS2;PGM2
Gap junction,5/88,0.4509193850280069,1,0,0,1.1363636363636362,0.9050757984351353,GNAI3;LPAR1;MAPK1;DRD1;EGFR
Insulin resistance,6/108,0.45579415117862115,1,0,0,1.111111111111111,0.8730155491595808,PRKAA1;IRS1;RPS6KA2;PRKCZ;ACACB;INS
Retrograde endocannabinoid signaling,8/148,0.46236222561490486,1,0,0,1.0810810810810811,0.8339531426705211,NDUFB11;GNB1;CACNA1B;NAPEPLD;NDUFS3;GNAI3;MAPK1;NDUFV3
RIG-I-like receptor signaling pathway,4/70,0.4662992293725246,1,0,0,1.1428571428571428,0.8719174032140833,CYLD;IFNA7;DDX3X;ATG12
Non-alcoholic fatty liver disease (NAFLD),8/149,0.46993598574671025,1,0,0,1.0738255033557047,0.8109087721804916,PRKAA1;IRS1;NDUFB11;NDUFS3;NDUFV3;RAC1;SDHA;INS
Protein digestion and absorption,5/90,0.4705185605943169,1,0,0,1.111111111111111,0.8376887467502594,SLC15A1;COL1A2;COL4A4;SLC1A1;COL21A1
Propanoate metabolism,2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,LDHB;ACACB
Fatty acid biosynthesis,1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ACACB
Cholinergic synapse,6/112,0.49101551898111034,1,0,0,1.0714285714285714,0.7620852265724269,GNB1;CACNA1B;GNAI3;MAPK1;KCNQ5;CAMK2G
mTOR signaling pathway,8/152,0.49250496644326186,1,0,0,1.0526315789473684,0.7455270887074559,PRKAA1;CAB39;IRS1;FZD4;RPS6KA2;EIF4E1B;MAPK1;INS
Herpes simplex virus 1 infection,25/492,0.49637138340266174,1,0,0,1.0162601626016259,0.711819995503632,ZNF891;IFNA7;ITGB3;ZNF43;ZNF708;ZFP57;ZNF83;ZNF528;ZNF208;ZNF823;ZNF623;ZNF468;ZNF764;TAP2;ZNF705A;TAP1;ZNF12;HLA-F;POU2F3;ZFP69;ZNF716;ZNF658;ZNF554;ZNF432;ZNF596
Cytokine-cytokine receptor interaction,15/294,0.5057205436751088,1,0,0,1.0204081632653061,0.6956847423340725,IFNA7;IL31;TNFRSF12A;TGFB3;BMP8A;OSM;IL36G;TGFBR1;EPOR;THPO;IL2RB;CCL3;CCL1;TNFRSF4;CCR3
Glutamatergic synapse,6/114,0.5083474584006553,1,0,0,1.0526315789473684,0.7122000968180043,GRM7;SLC1A1;GNB1;GNAI3;MAPK1;PLD2
Bacterial invasion of epithelial cells,4/74,0.5098528753630284,1,0,0,1.0810810810810811,0.7282519724998587,DNM3;ARHGAP10;RHOG;RAC1
Regulation of lipolysis in adipocytes,3/55,0.5234350892650081,1,0,0,1.0909090909090908,0.706191545588209,IRS1;GNAI3;INS
"Alanine, aspartate and glutamate metabolism",2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,IL4I1;GAD2
Circadian entrainment,5/97,0.5371052771771576,1,0,0,1.0309278350515463,0.6407846977351693,RYR1;GNB1;GNAI3;MAPK1;CAMK2G
Tuberculosis,9/179,0.5415277319341373,1,0,0,1.005586592178771,0.6167875984468218,IFNA7;KSR1;IRAK2;TGFB3;NFYC;ITGAX;MAPK1;CLEC4E;CAMK2G
Olfactory transduction,22/444,0.5489292037258071,1,0,0,0.990990990990991,0.594382325067679,OR8H2;OR2T27;OR6F1;OR1D2;OR5H1;OR4K17;OR1L1;OR2T12;OR10AD1;OR2L13;GNB1;OR4C45;OR4A47;OR51B5;OR10A2;OR2B6;OR2A5;OR4C15;OR7C1;CAMK2G;OR4C3;OR4A16
Synaptic vesicle cycle,4/78,0.5517212852986342,1,0,0,1.0256410256410255,0.6099613109295229,DNM3;SLC1A1;CACNA1B;SLC6A3
Progesterone-mediated oocyte maturation,5/99,0.5554224977737025,1,0,0,1.01010101010101,0.5939658561566864,RPS6KA2;CDC16;GNAI3;MAPK1;INS
Primary immunodeficiency,2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,TAP2;TAP1
Thyroid cancer,2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,TPR;MAPK1
RNA degradation,4/79,0.561890006637219,1,0,0,1.0126582278481011,0.5837459908567373,PAN2;CNOT6L;PABPC4;EDC3
Pathways in cancer,26/530,0.5691186498287897,1,0,0,0.9811320754716981,0.5530311291468017,FH;IFNA7;PTGER1;LAMA3;LPAR1;GNAI3;EGFR;TPR;RAC3;MAPK1;ELOB;HES1;RAC1;CAMK2G;SMAD2;GSTO2;FZD4;TGFB3;F2;TGFBR1;EPOR;HEYL;KITLG;COL4A4;IL2RB;GNB1
VEGF signaling pathway,3/59,0.5713815260202666,1,0,0,1.0169491525423728,0.5691845296161483,RAC3;MAPK1;RAC1
Melanogenesis,5/101,0.5733754172932677,1,0,0,0.9900990099009901,0.5507075230503586,KITLG;FZD4;GNAI3;MAPK1;CAMK2G
Phenylalanine metabolism,1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,IL4I1
Primary bile acid biosynthesis,1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CYP39A1
Platelet activation,6/124,0.5912375561010063,1,0,0,0.9677419354838709,0.5085845672526835,COL1A2;ITGB3;GNAI3;MAPK1;F2;PRKCZ
Adrenergic signaling in cardiomyocytes,7/145,0.5920854218584392,1,0,0,0.9655172413793103,0.5060317966611959,KCNE1;GNAI3;ATP2B4;MAPK1;CAMK2G;RAPGEF3;MYH6
Oocyte meiosis,6/125,0.5991206229248341,1,0,0,0.96,0.4918006342162246,RPS6KA2;CDC16;MAPK1;FBXO43;CAMK2G;INS
Toll-like receptor signaling pathway,5/104,0.599573857726415,1,0,0,0.9615384615384616,0.49186164733317733,IFNA7;CCL3;MAPK1;MAP3K8;RAC1
Calcium signaling pathway,9/188,0.6010901477918724,1,0,0,0.9574468085106382,0.4873503440770302,RYR1;PTGER1;TNNC2;CACNA1B;ATP2B4;DRD1;HTR4;CAMK2G;EGFR
Other glycan degradation,1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,FUCA1
Chemokine signaling pathway,9/190,0.6138065265282766,1,0,0,0.9473684210526315,0.4623873194507082,GNB1;GNAI3;CCL3;RAC3;MAPK1;CCL1;RAC1;PRKCZ;CCR3
Osteoclast differentiation,6/127,0.6146383855730021,1,0,0,0.9448818897637795,0.45989402366767695,CYLD;ITGB3;MAPK1;RAC1;LILRB2;TGFBR1
Bladder cancer,2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,MAPK1;EGFR
Fat digestion and absorption,2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,MOGAT2;PNLIP
Graft-versus-host disease,2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,KIR3DL2;HLA-F
Ras signaling pathway,11/232,0.6151143798879258,1,0,0,0.9482758620689654,0.46081185293266835,KITLG;KSR1;GNB1;RAC3;MAPK1;RAC1;KSR2;EGFR;PLA1A;PLD2;INS
Cytosolic DNA-sensing pathway,3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,ZBP1;IFNA7;POLR2F
"Parathyroid hormone synthesis, secretion and action",5/106,0.6165249871762161,1,0,0,0.9433962264150944,0.4562796476411569,NR4A2;GNAI3;MAPK1;EGFR;PLD2
Human immunodeficiency virus 1 infection,10/212,0.6203155438584437,1,0,0,0.9433962264150944,0.4504971591535261,IFNA7;GNB1;GNAI3;TAP2;RAC3;TAP1;MAPK1;ELOB;RAC1;HLA-F
Gastric cancer,7/149,0.6208672064504345,1,0,0,0.9395973154362416,0.44784783988129884,SMAD2;TGFB3;FZD4;REG4;MAPK1;TGFBR1;EGFR
Glycosaminoglycan degradation,1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,HPSE
Steroid biosynthesis,1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,LIPA
Th17 cell differentiation,5/107,0.6248402405451496,1,0,0,0.9345794392523363,0.43949465144730016,SMAD2;IL2RB;MAPK1;AHR;TGFBR1
Salmonella infection,4/86,0.6293463661035574,1,0,0,0.9302325581395349,0.4307660579611482,RHOG;CCL3;MAPK1;RAC1
Central carbon metabolism in cancer,3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,MAPK1;EGFR;PDK1
Mitophagy,3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,UBB;BNIP3;AMBRA1
Shigellosis,3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,RHOG;MAPK1;RAC1
One carbon pool by folate,1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,TYMS
Dopaminergic synapse,6/131,0.6446363815048852,1,0,0,0.916030534351145,0.4022004922971754,GNB1;CACNA1B;GNAI3;DRD1;CAMK2G;SLC6A3
Natural killer cell mediated cytotoxicity,6/131,0.6446363815048852,1,0,0,0.916030534351145,0.4022004922971754,NCR2;IFNA7;RAC3;MAPK1;RAC1;KIR3DL2
Fatty acid degradation,2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,ECI1;ADH5
GABAergic synapse,4/89,0.6561310542796738,1,0,0,0.898876404494382,0.3787817816859613,GNB1;CACNA1B;GNAI3;GAD2
Amphetamine addiction,3/68,0.6676380497864279,1,0,0,0.8823529411764706,0.3564786122927678,DRD1;CAMK2G;SLC6A3
Fc epsilon RI signaling pathway,3/68,0.6676380497864279,1,0,0,0.8823529411764706,0.3564786122927678,RAC3;MAPK1;RAC1
Glycolysis / Gluconeogenesis,3/68,0.6676380497864279,1,0,0,0.8823529411764706,0.3564786122927678,LDHB;PGM2;ADH5
Focal adhesion,9/199,0.6683313701725119,1,0,0,0.9045226130653267,0.36449653143765454,COL1A2;COL4A4;ITGB3;LAMA3;RAPGEF1;RAC3;MAPK1;RAC1;EGFR
Dilated cardiomyopathy (DCM),4/91,0.6732482464251353,1,0,0,0.8791208791208791,0.34781639730574376,SGCB;TGFB3;ITGB3;MYH6
Fc gamma R-mediated phagocytosis,4/91,0.6732482464251353,1,0,0,0.8791208791208791,0.34781639730574376,MAPK1;RAC1;ASAP2;PLD2
Morphine addiction,4/91,0.6732482464251353,1,0,0,0.8791208791208791,0.34781639730574376,GNB1;CACNA1B;GNAI3;DRD1
Adipocytokine signaling pathway,3/69,0.6772948191670352,1,0,0,0.8695652173913043,0.338824888725687,PRKAA1;IRS1;ACACB
Ubiquitin mediated proteolysis,6/137,0.6868931771447399,1,0,0,0.8759124087591241,0.3289721085839843,UBA7;NEDD4;CDC16;SYVN1;ELOB;BRCA1
GnRH signaling pathway,4/93,0.6897669196744971,1,0,0,0.8602150537634409,0.3194851922842808,MAPK1;CAMK2G;EGFR;PLD2
Mismatch repair,1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,RPA3
Amino sugar and nucleotide sugar metabolism,2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,PGM2;RENBP
Endocrine and other factor-regulated calcium reabsorption,2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,DNM3;RAB11A
Arrhythmogenic right ventricular cardiomyopathy (ARVC),3/72,0.7050123870135998,1,0,0,0.8333333333333333,0.2912832550768055,SGCB;ITGB3;PKP2
JAK-STAT signaling pathway,7/162,0.7061186960436059,1,0,0,0.8641975308641975,0.300716483504727,IFNA7;THPO;IL2RB;OSM;EGFR;EPOR;PTPN2
Necroptosis,7/162,0.7061186960436059,1,0,0,0.8641975308641975,0.300716483504727,ZBP1;CYLD;IFNA7;USP21;TRPM7;HMGB1;CAMK2G
Vitamin digestion and absorption,1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,PNLIP
Malaria,2/49,0.7104927276749392,1,0,0,0.8163265306122448,0.2790176057147895,TGFB3;PECAM1
Hepatitis B,7/163,0.7121164303112548,1,0,0,0.8588957055214724,0.29160699221433833,SMAD2;IFNA7;DDX3X;TGFB3;MAPK1;HSPG2;TGFBR1
Cholesterol metabolism,2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,ABCB11;LIPA
Glycerophospholipid metabolism,4/97,0.7210011321847114,1,0,0,0.8247422680412371,0.269785213526288,LYPLA2;GPAM;DGKA;PLD2
Hematopoietic cell lineage,4/97,0.7210011321847114,1,0,0,0.8247422680412371,0.269785213526288,KITLG;THPO;ITGB3;EPOR
Inositol phosphate metabolism,3/74,0.722455815470999,1,0,0,0.8108108108108109,0.2635937966943547,INPP5A;MTMR14;INPP5J
Metabolism of xenobiotics by cytochrome P450,3/74,0.722455815470999,1,0,0,0.8108108108108109,0.2635937966943547,GSTO2;UGT2A3;ADH5
AMPK signaling pathway,5/120,0.7226056756270708,1,0,0,0.8333333333333333,0.2707430048728052,PRKAA1;CAB39;IRS1;ACACB;INS
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,PIGW
Protein processing in endoplasmic reticulum,7/165,0.7238641717074015,1,0,0,0.8484848484848485,0.2741891619820413,DNAJB2;ERO1B;GANAB;MAN1C1;SYVN1;DNAJC5G;SEC62
Pancreatic secretion,4/98,0.7284348779278988,1,0,0,0.8163265306122448,0.25865881578997496,ATP2B4;RAC1;PNLIP;RAB11A
Glioma,3/75,0.7308710279969972,1,0,0,0.7999999999999999,0.2508146136696121,MAPK1;CAMK2G;EGFR
Amyotrophic lateral sclerosis (ALS),2/51,0.7310789651903944,1,0,0,0.7843137254901961,0.24567356984329963,NEFM;RAC1
Mineral absorption,2/51,0.7310789651903944,1,0,0,0.7843137254901961,0.24567356984329963,TRPM7;ATOX1
Phosphatidylinositol signaling system,4/99,0.7357196016371502,1,0,0,0.8080808080808081,0.24800501727640314,INPP5A;DGKA;MTMR14;INPP5J
Chronic myeloid leukemia,3/76,0.739084180089673,1,0,0,0.7894736842105262,0.2386922002972212,TGFB3;MAPK1;TGFBR1
Hepatocellular carcinoma,7/168,0.7408637352815205,1,0,0,0.8333333333333333,0.2499488030031976,SMAD2;GSTO2;TGFB3;FZD4;MAPK1;TGFBR1;EGFR
Regulation of actin cytoskeleton,9/214,0.7483285391762075,1,0,0,0.8411214953271027,0.2438522023798273,ITGB3;LPAR1;ITGAX;RAC3;MAPK1;RAC1;F2;EGFR;INS
Breast cancer,6/147,0.7496501617847804,1,0,0,0.8163265306122448,0.23522337324693435,HEYL;FZD4;MAPK1;HES1;BRCA1;EGFR
Ascorbate and aldarate metabolism,1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,UGT2A3
Autoimmune thyroid disease,2/53,0.7504077852742062,1,0,0,0.7547169811320754,0.21670830680118947,IFNA7;HLA-F
Tight junction,7/170,0.7517812588214371,1,0,0,0.8235294117647058,0.23496107482455797,PRKAA1;NEDD4;RAPGEF2;AMOTL2;RAC1;PRKCZ;LLGL1
Longevity regulating pathway,4/102,0.7566871822236416,1,0,0,0.7843137254901961,0.21867085840898748,PRKAA1;IRS1;EIF4E1B;INS
Butanoate metabolism,1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,GAD2
Glucagon signaling pathway,4/103,0.7633839575456066,1,0,0,0.7766990291262135,0.20970419679401037,LDHB;PRKAA1;ACACB;CAMK2G
Legionellosis,2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,CLK1;BNIP3
C-type lectin receptor signaling pathway,4/104,0.7699363530876122,1,0,0,0.7692307692307693,0.20111340452197826,CYLD;KSR1;MAPK1;CLEC4E
Human T-cell leukemia virus 1 infection,9/219,0.7718008106095379,1,0,0,0.821917808219178,0.21290036679018165,ELK4;SMAD2;KAT5;TGFB3;CDC16;IL2RB;MAPK1;HLA-F;TGFBR1
Glutathione metabolism,2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,GSTO2;LAP3
Phagosome,6/152,0.7773915271524404,1,0,0,0.7894736842105262,0.19879828387763243,ITGB3;TAP2;M6PR;TAP1;RAC1;HLA-F
Oxytocin signaling pathway,6/153,0.7826524992964198,1,0,0,0.7843137254901961,0.19220901041264157,RYR1;PRKAA1;GNAI3;MAPK1;CAMK2G;EGFR
Chemical carcinogenesis,3/82,0.7842396846897038,1,0,0,0.7317073170731706,0.17783457445402553,GSTO2;UGT2A3;ADH5
Glyoxylate and dicarboxylate metabolism,1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,GRHPR
Nicotinate and nicotinamide metabolism,1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,NMNAT1
Viral carcinogenesis,8/201,0.7925273344506804,1,0,0,0.7960199004975124,0.18509714022296506,GTF2A1L;DDX3X;MAPK1;GTF2H1;RAC1;HLA-F;GTF2E1;CCR3
Endometrial cancer,2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,MAPK1;EGFR
Drug metabolism,4/108,0.7947283904475327,1,0,0,0.7407407407407407,0.1701887925469081,GSTO2;UGT2A3;FMO4;ADH5
Circadian rhythm,1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,PRKAA1
Galactose metabolism,1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,PGM2
Mucin type O-glycan biosynthesis,1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,C1GALT1
RNA polymerase,1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,POLR2F
beta-Alanine metabolism,1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,GAD2
ErbB signaling pathway,3/85,0.8042799356196909,1,0,0,0.7058823529411764,0.15374674713305503,MAPK1;CAMK2G;EGFR
Base excision repair,1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,HMGB1
Cellular senescence,6/160,0.8168643739779579,1,0,0,0.7499999999999999,0.15171165211906248,SMAD2;TGFB3;MAPK1;TRPM7;HLA-F;TGFBR1
Leukocyte transendothelial migration,4/112,0.8173248241169633,1,0,0,0.7142857142857142,0.14408477257015773,PECAM1;GNAI3;RAC1;RAPGEF3
Toxoplasmosis,4/113,0.8226434279131911,1,0,0,0.7079646017699115,0.13821765033879096,TGFB3;LAMA3;GNAI3;MAPK1
Pentose and glucuronate interconversions,1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,UGT2A3
Kaposi sarcoma-associated herpesvirus infection,7/186,0.8273600898825334,1,0,0,0.7526881720430108,0.1426458959005734,IFNA7;UBB;GNB1;MAPK1;RAC1;HLA-F;CCR3
Thyroid hormone signaling pathway,4/116,0.8378353080759515,1,0,0,0.689655172413793,0.1220232603840384,MED30;ITGB3;MAPK1;MYH6
RNA transport,6/165,0.8385956609296656,1,0,0,0.7272727272727272,0.12801935886721602,EIF4E1B;PABPC4;EIF4A3;TPR;SMN1;RPP25L
DNA replication,1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,RPA3
Starch and sucrose metabolism,1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,PGM2
cGMP-PKG signaling pathway,6/166,0.8426824754400535,1,0,0,0.7228915662650601,0.1237337726371208,IRS1;CNGA1;GNAI3;ATP2B4;MAPK1;INS
Inflammatory bowel disease (IBD),2/65,0.8428493095437481,1,0,0,0.6153846153846154,0.10521051812214251,SMAD2;TGFB3
Human papillomavirus infection,13/330,0.846703018338269,1,0,0,0.7878787878787877,0.13110718519296471,IFNA7;FZD4;ITGB3;LAMA3;HLA-F;PRKCZ;EGFR;HEYL;COL1A2;COL4A4;MAPK1;HES1;LLGL1
Non-small cell lung cancer,2/66,0.8489478345965421,1,0,0,0.6060606060606061,0.09924699267132996,MAPK1;EGFR
African trypanosomiasis,1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,F2RL1
Retinol metabolism,2/67,0.8548301611907013,1,0,0,0.5970149253731343,0.0936432666623936,UGT2A3;ADH5
Allograft rejection,1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,HLA-F
Epithelial cell signaling in Helicobacter pylori infection,2/68,0.860502636162266,1,0,0,0.588235294117647,0.08837564694787858,RAC1;EGFR
Alzheimer disease,6/171,0.8618729388874423,1,0,0,0.7017543859649122,0.10431398025689025,BACE1;NDUFB11;NDUFS3;MAPK1;NDUFV3;SDHA
Renin secretion,2/69,0.8659715129706728,1,0,0,0.5797101449275363,0.08342218313842696,EDN3;GNAI3
Prostate cancer,3/97,0.8694002721574682,1,0,0,0.6185567010309279,0.08656802931150201,MAPK1;EGFR;INS
Prolactin signaling pathway,2/70,0.8712429450339811,1,0,0,0.5714285714285714,0.0787625225498065,MAPK1;INS
Ferroptosis,1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,PRNP
Nicotine addiction,1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,CACNA1B
Cell cycle,4/124,0.8730902649815165,1,0,0,0.6451612903225806,0.08755892398339275,SMAD2;TGFB3;CDC16;SFN
Aldosterone synthesis and secretion,3/98,0.8738518002871013,1,0,0,0.6122448979591836,0.08255784648566498,NR4A2;ATP2B4;CAMK2G
Epstein-Barr virus infection,7/201,0.8805619416668193,1,0,0,0.6965174129353233,0.08859353598323239,IFNA7;NEDD4;TAP2;TAP1;HES1;RAC1;HLA-F
Melanoma,2/72,0.8812175551168138,1,0,0,0.5555555555555555,0.07025041245674381,MAPK1;EGFR
p53 signaling pathway,2/72,0.8812175551168138,1,0,0,0.5555555555555555,0.07025041245674381,TP53AIP1;SFN
Tryptophan metabolism,1/42,0.8842793063304941,1,0,0,0.47619047619047616,0.05856300421956226,IL4I1
T cell receptor signaling pathway,3/101,0.8864097011888528,1,0,0,0.594059405940594,0.07162931796059352,MAPK1;MAP3K8;CARD11
Leishmaniasis,2/74,0.8904734986911036,1,0,0,0.5405405405405406,0.06270374958254536,TGFB3;MAPK1
Alcoholism,6/180,0.8915261259625002,1,0,0,0.6666666666666666,0.07654702432386451,GNB1;CRH;GNAI3;MAPK1;DRD1;SLC6A3
Purine metabolism,4/129,0.8915945370687862,1,0,0,0.6201550387596899,0.07115894858860422,PRPS2;PDE6G;PGM2;PDE6C
Gastric acid secretion,2/75,0.8948461559431564,1,0,0,0.5333333333333333,0.0592551830845253,GNAI3;CAMK2G
Vasopressin-regulated water reabsorption,1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,RAB11A
Thermogenesis,8/231,0.8962982682392014,1,0,0,0.6926406926406926,0.07583171099049017,PRKAA1;KDM1A;NDUFB11;RPS6KA2;BMP8A;NDUFS3;NDUFV3;SDHA
Pertussis,2/76,0.8990559259149057,1,0,0,0.5263157894736842,0.056005282852014004,GNAI3;MAPK1
Proteasome,1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,PSMA7
Oxidative phosphorylation,4/133,0.9046524128561665,1,0,0,0.6015037593984962,0.060273373383263405,NDUFB11;NDUFS3;NDUFV3;SDHA
Transcriptional misregulation in cancer,6/186,0.9081344372566347,1,0,0,0.6451612903225806,0.06216958237920191,ELK4;FUT8;CCNT1;TSPAN7;IL2RB;MLLT3
Ether lipid metabolism,1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,PLD2
Hedgehog signaling pathway,1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,GAS1
Sphingolipid metabolism,1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,ACER3
Notch signaling pathway,1/48,0.914994048233663,1,0,0,0.41666666666666663,0.03701571599601437,HES1
"Valine, leucine and isoleucine degradation",1/48,0.914994048233663,1,0,0,0.41666666666666663,0.03701571599601437,IL4I1
TNF signaling pathway,3/110,0.9176399007049346,1,0,0,0.5454545454545454,0.04688194382454664,RPS6KA4;MAPK1;MAP3K8
Ovarian steroidogenesis,1/49,0.919254474341766,1,0,0,0.4081632653061224,0.034364200583535946,INS
Insulin secretion,2/86,0.9333063042418757,1,0,0,0.46511627906976744,0.032103177510297835,CAMK2G;INS
Influenza A,5/171,0.9335483701649325,1,0,0,0.5847953216374269,0.04021198913385291,CPSF4;IFNA7;MAPK1;FURIN;BCL2L2-PABPN1
Salivary secretion,2/90,0.9436483877912323,1,0,0,0.4444444444444444,0.025778512347182387,ATP2B4;PRH2
Rheumatoid arthritis,2/91,0.9459848142593618,1,0,0,0.43956043956043955,0.024408247313871943,TGFB3;CCL3
Pyrimidine metabolism,1/57,0.9464904210788941,1,0,0,0.3508771929824561,0.01929629078749377,TYMS
NOD-like receptor signaling pathway,5/178,0.946680501203607,1,0,0,0.5617977528089887,0.030782934075452524,PANX1;IFNA7;MAPK1;TRPM7;ATG12
Th1 and Th2 cell differentiation,2/92,0.9482287784921883,1,0,0,0.43478260869565216,0.02311281666022285,IL2RB;MAPK1
Small cell lung cancer,2/93,0.9503836736321627,1,0,0,0.43010752688172044,0.021887960833825593,COL4A4;LAMA3
Ribosome,4/153,0.9511575630869465,1,0,0,0.5228758169934641,0.026183293427957225,RPS15;RPL36AL;RPL15;RPL29
Lysine degradation,1/59,0.95172205472190885,1,0,0,0.3389830508474576,0.01677364276098951,KMT2D
Steroid hormone biosynthesis,1/60,0.95414298697788,1,0,0,0.3333333333333333,0.015647245745596144,UGT2A3
Basal cell carcinoma,1/63,0.9607020222041087,1,0,0,0.31746031746031744,0.012727297981234762,FZD4
Inflammatory mediator regulation of TRP channels,2/100,0.9632369873558141,1,0,0,0.39999999999999997,0.014982321868347009,F2RL1;CAMK2G
Vascular smooth muscle contraction,3/132,0.9638421946522369,1,0,0,0.45454545454545453,0.0167398619387193,PPP1R14A;EDN3;MAPK1
Ribosome biogenesis in eukaryotes,2/101,0.9647890418591292,1,0,0,0.396039603960396,0.014196360797659355,RPP25L;GNL3
Acute myeloid leukemia,1/66,0.9663236546235302,1,0,0,0.30303030303030304,0.010380743845736572,MAPK1
Huntington disease,5/193,0.967247244864982,1,0,0,0.5181347150259067,0.01725447348516611,NDUFB11;NDUFS3;POLR2F;NDUFV3;SDHA
Staphylococcus aureus infection,1/68,0.9696175495526317,1,0,0,0.2941176470588235,0.009074577660222398,FPR3
Estrogen signaling pathway,3/137,0.9702000312158441,1,0,0,0.43795620437956206,0.013249493867024583,GNAI3;MAPK1;EGFR
Signaling pathways regulating pluripotency of stem cells,3/139,0.9724341820362676,1,0,0,0.4316546762589928,0.012065993490628802,SMAD2;FZD4;MAPK1
Bile secretion,1/72,0.9752710378445755,1,0,0,0.27777777777777773,0.006955516411879717,ABCB11
Apoptosis,3/143,0.976434855145595,1,0,0,0.4195804195804196,0.01000583642991821,TP53AIP1;DFFA;MAPK1
PPAR signaling pathway,1/74,0.9776904281936729,1,0,0,0.2702702702702703,0.00609789044447976,DBI
Thyroid hormone synthesis,1/74,0.9776904281936729,1,0,0,0.2702702702702703,0.00609789044447976,ASGR2
Cell adhesion molecules (CAMs),3/145,0.9782218699760653,1,0,0,0.41379310344827586,0.009111216728335437,SPN;PECAM1;HLA-F
Cardiac muscle contraction,1/78,0.9818427613794292,1,0,0,0.2564102564102564,0.004698488267500739,MYH6
MicroRNAs in cancer,8/299,0.9841281952173011,1,0,0,0.5351170568561873,0.008561397042497167,MIR126;MIR137;MIR331;IRS1;ITGB3;MAPK1;BRCA1;EGFR
Hepatitis C,3/155,0.9853816332969996,1,0,0,0.3870967741935484,0.0057004907906696945,IFNA7;MAPK1;EGFR
Taste transduction,1/83,0.9859645609779344,1,0,0,0.24096385542168675,0.0034059921056594548,SCN3A
Systemic lupus erythematosus,2/133,0.9914288561400509,1,0,0,0.3007518796992481,0.0025888984552419132,C8G;C7
IL-17 signaling pathway,1/93,0.9916148544307698,1,0,0,0.21505376344086022,0.0018108599286685806,MAPK1
NF-kappa B signaling pathway,1/95,0.9924358915832194,1,0,0,0.21052631578947367,0.0015984971305800805,CARD11
Measles,2/138,0.9931595044241683,1,0,0,0.2898550724637681,0.0019895649305631904,IFNA7;IL2RB
